Focal Cortical Dysplasia Type II Detection Using Cross Modality Transfer Learning and Grad-CAM in 3D-CNNs for MRI Analysis
It addresses a difficult diagnosis problem for epilepsy patients, with incremental improvements in AI-based medical diagnostics.
This study tackled the detection of focal cortical dysplasia type II, a cause of drug-resistant epilepsy, by using 3D-CNNs with cross-modality transfer learning and Grad-CAM on MRI data, achieving up to 80.3% classification accuracy and improved interpretability via a Heat-Score metric.
Focal cortical dysplasia (FCD) type II is a major cause of drug-resistant epilepsy, often curable only by surgery. Despite its clinical importance, the diagnosis of FCD is very difficult in MRI because of subtle abnormalities, leading to misdiagnosis. This study investigates the use of 3D convolutional neural networks (3D-CNNs) for FCD detection, using a dataset of 170 subjects (85 FCD patients and 85 controls) composed of T1-weighted and FLAIR MRI scans. In particular, it investigates the benefits obtained from cross-modality transfer learning and explainable artificial intelligence (XAI) techniques, in particular Gradient-weighted Class Activation Mapping (Grad-CAM). ResNet architectures (ResNet-18, -34, and -50) were implemented, employing transfer learning strategies that used pre-trained weights from segmentation tasks. Results indicate that transfer learning significantly enhances classification accuracy (up to 80.3%) and interpretability, as measured by a novel Heat-Score metric, which evaluates the model's focus on clinically relevant regions. Improvements in the Heat-Score metric underscore the model's seizure zone localization capabilities, bringing AI predictions and clinical insights closer together. These results highlight the importance of transfer learning, including cross-modality, and XAI in advancing AI-based medical diagnostics, especially for difficult-to-diagnose pathologies such as FCD.